These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20379582)

  • 1. Preparation and characterization of lectin-conjugated chitosan fluorescent nanoparticles.
    Liu J; Zhang L; Wang C; Xu H; Zhao X
    Mol Biosyst; 2010 Jun; 6(6):954-7. PubMed ID: 20379582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J; Chen XG; Peng WB; Liu CS
    Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
    Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
    J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes.
    Xu X; Capito RM; Spector M
    J Biomed Mater Res A; 2008 Mar; 84(4):1038-48. PubMed ID: 17685397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
    Mi FL; Wu YY; Chiu YL; Chen MC; Sung HW; Yu SH; Shyu SS; Huang MF
    Biomacromolecules; 2007 Mar; 8(3):892-8. PubMed ID: 17316043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and characterization of biotinylated chitosan nanoparticles].
    Yao Q; Hou SX; Zhang X; Zhao G; Gou XJ; You JZ
    Yao Xue Xue Bao; 2007 May; 42(5):557-61. PubMed ID: 17703783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and characterization of chitosan-DNA nanoparticles as gene carriers].
    Su D; Ji AM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):595-8. PubMed ID: 17545064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly biocompatible multi-walled carbon nanotube-chitosan nanoparticle hybrids as protein carriers.
    Li C; Yang K; Zhang Y; Tang H; Yan F; Tan L; Xie Q; Yao S
    Acta Biomater; 2011 Aug; 7(8):3070-7. PubMed ID: 21601019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent nanoparticles of chitosan complex for real-time monitoring drug release.
    Cui W; Lu X; Cui K; Wu J; Wei Y; Lu Q
    Langmuir; 2011 Jul; 27(13):8384-90. PubMed ID: 21661743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the aminated agarose nanoparticles labeled with fluorescein isothiocyanate.
    Zhang LM; Huang JY; Zhang LH; Chu B; Tang SQ
    Scanning; 2010; 32(6):361-8. PubMed ID: 20938971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homogeneous, competitive fluorescence quenching immunoassay based on gold nanoparticle/polyelectrolyte coated latex particles.
    Kato N; Caruso F
    J Phys Chem B; 2005 Oct; 109(42):19604-12. PubMed ID: 16853535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells.
    Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC
    Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
    Wang S; Jiang T; Ma M; Hu Y; Zhang J
    Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent chitosan functionalized magnetic polymeric nanoparticles: Cytotoxicity and in vitro evaluation of cellular uptake.
    Kaewsaneha C; Jangpatarapongsa K; Tangchaikeeree T; Polpanich D; Tangboriboonrat P
    J Biomater Appl; 2014 Nov; 29(5):761-8. PubMed ID: 24951458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
    Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin.
    Chuah AM; Kuroiwa T; Ichikawa S; Kobayashi I; Nakajima M
    J Food Sci; 2009; 74(1):N1-8. PubMed ID: 19200109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic bead-based fluorometric detection of lectin-glycoprotein interactions.
    Rambihar C; Kerman K
    Talanta; 2010 Jun; 81(4-5):1676-80. PubMed ID: 20441957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
    Park JS; Han TH; Lee KY; Han SS; Hwang JJ; Moon DH; Kim SY; Cho YW
    J Control Release; 2006 Sep; 115(1):37-45. PubMed ID: 16935380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.